Great Lakes Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.06M Sell
52,651
-98,690
-65% -$2.65M 0.01% 470
2026
Q2
$3.83M Sell
151,341
-90,486
-37% -$1.99M 0.03% 293
2026
Q1
$5.38M Sell
241,827
-71,709
-23% -$1.71M 0.04% 211
2025
Q4
$8.37M Sell
313,536
-141,254
-31% -$3.38M 0.07% 171
2025
Q3
$9.7M Sell
454,790
-333,245
-42% -$7.88M 0.08% 168
2025
Q2
$17M Buy
788,035
+175,355
+29% +$3.26M 0.14% 137
2025
Q1
$10.2M Buy
612,680
+72,667
+13% +$1.32M 0.09% 192
2024
Q4
$9.9M Buy
+540,013
New +$8.72M 0.08% 203
2021
Q2
– Sell
-482,666
Closed -$12.5M – 703
2021
Q1
$12.5M Buy
482,666
+32,152
+7% +$1.42M 0.2% 157
2020
Q4
$24.1M Buy
+450,514
New +$22.4M 0.44% 66
2018
Q4
– Sell
-202,452
Closed -$4.2M – 558
2018
Q3
$4.2M Sell
202,452
-11,521
-5% -$181K 0.09% 219
2018
Q2
$3.27M Buy
+213,973
New +$3.82M 0.08% 252

Other funds holding ACAD

Great Lakes Advisors's ACAD Position: Q3 2026 in Review

Great Lakes Advisors reduced its Acadia Pharmaceuticals (ACAD) stake by 65% in Q3 2026, selling an estimated $2.65M and leaving 52,651 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #470.

Great Lakes Advisors first reported a position in ACAD in Q2 2018 and has held it in 12 quarters since. The position peaked at $24.1M in Q4 2020. 351 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.

  • Great Lakes Advisors held 52,651 shares of Acadia Pharmaceuticals worth $1.06M as of Q3 2026.
  • Great Lakes Advisors sold 98,690 Acadia Pharmaceuticals shares in Q3 2026, an estimated $2.65M.
  • Acadia Pharmaceuticals made up 0.01% of Great Lakes Advisors's portfolio in Q3 2026, its #470 holding.
  • Great Lakes Advisors first reported a position in Acadia Pharmaceuticals in Q2 2018 and has held it in 12 quarters since.
  • Great Lakes Advisors's Acadia Pharmaceuticals position peaked at $24.1M in Q4 2020.
  • 351 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.

Based on Great Lakes Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.